Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
Qizhen Shi(Children's Hospital of Wisconsin)
Cited by 188
Related Papers
Immune tolerance induced by platelet‐targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated
|Journal of Thrombosis and Haemostasis|2017|34
The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity
|Blood|2015|25
Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice
|Journal of Thrombosis and Haemostasis|2016|21
Platelet Gene Therapy Promotes Targeted Peripheral Tolerance by Clonal Deletion and Induction of Antigen-Specific Regulatory T Cells
|Frontiers in Immunology|2018|15
Comparison of platelet‐derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay
|Journal of Thrombosis and Haemostasis|2015|14